All Articles

A new federal directive urges states to phase out mercury dental fillings in Medicaid, a strategic shift impacting millions and aligning U.S. policy with global health goals.

Beyond market tailwinds, Franklin Templeton's record assets reveal a deliberate strategy of acquisition, a pivot to alternatives, and key tech innovation.

The logistics giant heads to a key summit with strong results, but can it prove its 'Lean AI' is a real competitive moat and not just market buzz?

Bristol Myers Squibb's large-scale deployment of Schrödinger's Bunsen AI isn't just a software deal; it's a strategic signal for the future of pharma R&D.

As AI agents begin to manage billions in ad spend, PubMatic's new framework offers a critical layer of control. Is this the key to unlocking trust?

Colossal’s new fund pairs genetic engineering with grassroots conservation, offering a high-tech, high-stakes lifeline to species from ferrets to sea stars.

TestMu AI is giving developers a head start on Samsung's new Z Fold8 and Fold8 Ultra, using agentic AI to solve the complex challenge of their opposing designs.

Acrivon's ACR-2316 shows durable responses in lung cancer, moving to the next phase. The trial's design, guided by AI, aligns with new FDA standards.

The mobile tech firm appoints a seasoned corporate finance and crypto veteran, signaling a new era focused on strategic growth and financial engineering.

As insurers move from AI experiments to enterprise-wide adoption, a new category of software is emerging to manage the chaos. Here's what it means for the industry.

As Lifespace celebrates 50 years of purpose-driven senior living, a look beneath the surface reveals a tension between its inspiring mission and complex financials.

Ad tech firm Shirofune is launching 'Creative Timeline,' a patent-pending AI feature designed to end creative silos and make ad performance data intuitive.

A new report reveals a seismic shift in political strategy. As campaigns gear up for the 2026 midterms, data shows mass outreach is failing. The key to persuasion? Deep cultural relevance.

As Flowers Foods preps its Q2 results amid a plummeting stock price, the bakery giant's strategic pivot towards health trends and fiscal discipline faces a critical test.

Optiv unveils Agentic Security Operations, a leap beyond traditional MDR. By fusing agentic AI with Google and Wiz, it promises a proactive, not reactive, future.

Focal Systems' new AI module scans forgotten inventory above shelves, helping retailers recover millions in lost value and dramatically slash labor costs.

A new survey reveals 99% of bankers face intense competition, with AI and stablecoins threatening to upend the financial system as we know it.

Caitlin Clark and Wilson unveil their third basketball line, a collection that showcases her evolution from star player to product co-creator and brand architect.

Expedition Therapeutics lands a huge Series B and starts a pivotal trial for a drug that could finally target the root cause of COPD for millions.

Marex's strategic investment in Digital Prime Technologies isn't just a deal; it's a blueprint for bringing Wall Street's rigor to digital asset lending.